首页 › 帕金森病 › 堪萨斯州 › Kansas City
Kansas City KS 帕金森病临床试验
8项针对 帕金森病的研究正在 Kansas City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
招募中2 期
- University of Kansas Medical Center, Kansas City
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
招募中2/3 期
- Site-029, Kansas City
A Study of Buntanetap in Participants With PD
招募中2/3 期
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D, Kansas City
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
招募中2 期
- The University of Kansas (KU) (Site #216), Kansas City
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
招募中3 期
- University of Kansas Medical Center, Kansas City
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
招募中3 期
- University of Kansas Medical Center, Kansas City
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
招募中观察性研究欢迎健康志愿者
- University of Kansas Medical Center, Kansas City
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
招募中4 期
- University of Kansas Medical Center, Kansas City
其他城市的 帕金森病试验
- New York City, NY23 项研究
- Boston, MA19 项研究
- Cleveland, OH18 项研究
- Minneapolis, MN17 项研究
- Nashville, TN15 项研究
- Philadelphia, PA14 项研究
- San Francisco, CA14 项研究
- New Haven, CT14 项研究
- Charleston, SC13 项研究
- Farmington Hills, MI13 项研究
- Chicago, IL13 项研究
- Miami, FL13 项研究
Kansas City的其他研究
- 心血管疾病14 项研究
- 心力衰竭13 项研究
- 肥胖症13 项研究
- 间质性肺病13 项研究
- 囊性纤维化13 项研究
- 乳腺癌12 项研究
- 膀胱癌12 项研究
- 急性髓系白血病12 项研究
- 前列腺癌12 项研究
- 非小细胞肺癌11 项研究
- 肺癌11 项研究
- 慢性阻塞性肺病9 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。